IIIT-Delhi collaborates with IBM to launch a PG Diploma Course in Data Science and AI

To cater to the upskilling needs of IT professionals, Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), collaborated with IBM to launch a Nine-month PG Diploma Program in Data Science and Artificial Intelligence. An MOU was signed between IIIT-Delhi and IBM for the same on 27th Dec 2019. The program will allow students as well as professionals to gain an edge in the field of Data science and Artificial Intelligence and help in developing skills that are hard to find in the desired industry.

To read the full story, please visit https://indiaeducationdiary.in/iiit-delhi-collaborates-with-ibm-to-launch-a-pg-diploma-course-in-data-science-and-ai/

IRIS 2020 - CONVERGENCE

SFIT Community watches Pariksha Pe Charcha 2020 by PM Narendra Modiji

Pinaka: Fast & accurate software verifier, developed at IIT Hyderabad

IITH team at SVCOMP 2020

SVCOMP is a Software Verification Competition which is the ultimate battleground for researchers around the world to prove the mettle of their verifiers on more than 10000 benchmark programs.

Pinaka, a symbolic execution engine designed and developed at IITH by Akash Banerjee, Eti Chaudhary and Dr. Saurabh Joshi participated in SVCOMP and placed 3rd in ReachSafety-Floats subcategory, 8th in ReachSafety category and 6th in Termination category. Pinaka was also one of the most accurate verifiers with only 3 errors in more than 6500 benchmarks it was run on.

More Details: https://sv-comp.sosy-lab.org/2020/

3D Printed Patient Specific Medical Implants technology transferred to the Industry

CSIR-Central Scientific Instruments Organisation (CSIR-CSIO) has transferred the knowhow of “3D Printed Patient Specific Medical Implants” to the industry. The requirement of such implants may arise due to trauma, diseases like cancer or fungal infection, revision surgeries etc.

Patient Specific Implant (PSI) are required when current commercially available implant for the site are either not available or doesn’t fulfill the anatomical requirement. In those cases PSI are designed for one particular patient from the CT-Scan data and then manufactured using 3D printing technology in Titanium or other biocompatible materials. The technology has been developed by CSIR-CSIO.

PSI are also beneficial for joint salvaging surgeries e.g. when human joints are good but bone near joints area is infected or traumatized. CSIR-CSIO has developed the know-how & expertise of PSI development for load bearing & non-load bearing anatomical sites.

To read the full study, please visit:

https://vigyanprasar.gov.in/isw/3D-Printed-Patient-Specific-Medical-Implants-technology-transferred-to-the-Industry.html

Genome Information to Help Precise and Personalized Healthcare

Researcher from India and USA, who work to understand the genetic basis of diseases among various ethnic populations from different parts of the world, participated in a workshop organized by CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad. The workshop focussed on understanding genome information in a better way. Improved information on genome can help fine-tune genome-assisted healthcare, and could even lead to precise, personalized, more effective and economical approaches to healthcare.

The three-day workshop, which started on January 16, is being attended by around 200 researchers, many of whom are promising PhD scholars from research institutes, universities, hospitals and life science companies in India and USA. This workshop is arranged by the Indo-US Science and Technology Forum, supported by the Department of Science and Technology, India, and Department of State, USA, with an aim to create fruitful collaborations between the two countries.

To read more, please visit:

https://vigyanprasar.gov.in/isw/Genome-Information-to-Help-Precise-and-Personalized-Healthcare.html

Study cautions about the use of designer receptors to control the brain

Chemogenetics is a technique that uses chemicals to understand how neurons are activated. It manipulates genes to place the neurons under the control of special receptors called DREADDS. Short for Designer Receptors Activated by Designer Drugs, these receptors only bind to an inert chemical called Clozapine-N-Oxide (CNO). In a recent study, researchers from the Tata Institute of Fundamental Research (TIFR), Mumbai, and Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR), Bengaluru, point out specific flaws in this technique. The study was published in the journal eNeuro and funded by the Department of Science and Technology and Scientific and Engineering Research Board.

To read the full study, please visit:

https://researchmatters.in/news/study-cautions-about-use-designer-receptors-control-brain